Yonsei Med J.  2009 Apr;50(2):245-251.

Outcomes in Neonates with Pulmonary Atresia and Intact Ventricular Septum Underwent Pulmonary Valvulotomy and Valvuloplasty Using a Flexible 2-French Radiofrequency Catheter

• Lee ML
• Tsao LY
• Chiu HY
• Chen M
• Chiu IS

Abstract

PURPOSE
Outcomes in 6 neonates with pulmonary atresia and intact ventricular septum (PAIVS) undergoing radiofrequency pulmonary valvulotomy and valvuloplasty (RPVV) were reported to identify the factors favorable for RPVV as the treatment of choice. MATERIALS AND METHODS: From May 2000 to January 2008, 6 patients with PAIVS were included in this retrospective study. They were aged 1 day to 90 days old. Study modalities included review of recordings of presentations and profiles of chest radiography, electrocardiography, echocardiography, and cardiac catheterization with angiography. Hemodynamic profiles from the echocardiography and the cardiac catheterization were analyzed. RESULTS: Echocardiography showed severe tricuspid regurgitation, membranous atresia of the pulmonary valve, intact ventricular septum, patent ductus arteriosus, and hypoplastic right ventricle in 6 patients. The pulmonary valve annulus were 4.2 to 6.9 mm in diameters, and those of the tricuspid valve were 7.1 to 10.1 mm. Elevated serum level of cardiac enzymes were found in 1 patient with ventriculocoronary communication (VCC). At cardiac catheterization, the ratio of systolic pressure of the right ventricle to that of the left ventricle ranged from 1.43 to 2.33 before RPVV, and from 0.54 to 1.15 after RPVV (p=0.027). The pressure gradients ranged from 76 to 136 mmHg before RPVV, and from 15 to 39 mmHg after RPVV (p=0.028). The echocardiographic gradients ranged from 16 to 32 mmHg within 24 hours after RPVV, and from 15 to 50 mmHg at the follow-ups. CONCLUSION: RPVV can be a treatment of choice for neonates with PAIVS, if there is patent infundibulum, no right-ventricular dependent coronary circulation, and adequate tricuspid valve and pulmonary valve.

Keyword

Pulmonary atresia; intact ventricular septum; radiofrequency; pulmonary valvulotomy; pulmonary valvuloplasty; unipolar; gradational balloon dilatation; Z values; ventriculocoronary communication

MeSH Terms

Balloon Dilatation/*methods
Echocardiography
Female
Heart Catheterization/*methods
Hemodynamics
Humans
Infant, Newborn
Male
Pulmonary Atresia/*surgery
Pulmonary Valve/abnormalities/*surgery
Treatment Outcome
*Ventricular Septum

Reference

1. de Leval M, Bull C, Hopkins R, Rees P, Deanfield J, Taylor JF, et al. Decision making in the definitive repair of the heart with a small right ventricle. Circulation. 1985. 72:II52–II60.

2. Milliken JC, Laks H, Hellenbrand W, George B, Chin A, Williams RG. Early and late results in the treatment of patients with pulmonary atresia and intact ventricular septum. Circulation. 1985. 72:II61–II69.

3. Hanley FL, Sade RM, Blackstone EH, Kirklin JW, Freedom RM, Nanda NC. Outcomes in neonatal pulmonary atresia with intact ventricular septum. A multiinstitutional study. J Thorac Cardiovasc Surg. 1993. 105:406–423. 424–427. discussion 423-4.

4. Humpl T, Söderberg B, McCrindle BW, Nykanen DG, Freedom RM, Williams WG, et al. Percutaneous balloon valvotomy in pulmonary atresia with intact ventricular septum: impact on patient care. Circulation. 2003. 108:826–832.

5. Wang JK, Wu MH, Chang CI, Chen YS, Lue HC. Outcomes of transcatheter valvotomy in patients with pulmonary atresia and intact ventricular septum. Am J Cardiol. 1999. 84:1055–1060.

6. Coles JG, Freedom RM, Lightfoot NE, Dasmahapatra HK, Williams WG, Trusler GA, et al. Long-term results in neonates with pulmonary atresia and intact ventricular septum. Ann Thorac Surg. 1989. 47:213–217.

7. Lightfoot NE, Coles JG, Dasmahapatra HK, Williams WG, Chin K, Trusler GA, et al. Analysis of survival in patients with pulmonary atresia and intact ventricular septum treated surgically. Int J Cardiol. 1989. 24:159–164.

8. Burrows PE, Freedom RM, Benson LN, Moes CA, Wilson G, Koike K, et al. Coronary angiography of pulmonary atresia, hypoplastic right ventricle, and ventriculocoronary communications. AJR Am J Roentgenol. 1990. 154:789–795.

9. Williams WG, Burrows P, Freedom RM, Trusler GA, Coles JG, Moes CA, et al. Thromboexclusion of the right ventricle in children with pulmonary atresia and intact ventricular septum. J Thorac Cardiovasc Surg. 1991. 101:222–229.

10. Giglia TM, Mandell VS, Connor AR, Mayer JE Jr, Lock JE. Diagnosis and management of right ventricle-dependent coronary circulation in pulmonary atresia with intact ventricular septum. Circulation. 1992. 86:1516–1528.

11. Calder AL, Co EE, Sage MD. Coronary arterial abnormalities in pulmonary atresia with intact ventricular septum. Am J Cardiol. 1987. 59:436–442.

12. Fyfe DA, Edwards WD, Driscoll DJ. Myocardial ischemia in patients with pulmonary atresia and intact ventricular septum. J Am Coll Cardiol. 1986. 8:402–406.

13. Freedom RM, White RI Jr, Ho CS, Gingell RL, Hawker RE, Rowe RD. Evaluation of patients with pulmonary atresia and intact ventricular septum by double catheter technique. Am J Cardiol. 1974. 33:892–895.

14. Qureshi SA, Rosenthal E, Tynan M, Anjos R, Baker EJ. Transcatheter laser-assisted balloon pulmonary valve dilation in pulmonic valve atresia. Am J Cardiol. 1991. 67:428–431.

15. Rosenthal E, Qureshi SA, Chan KC, Martin RP, Skehan DJ, Jordan SC, et al. Radiofrequency-assisted balloon dilatation in patients with pulmonary valve atresia and an intact ventricular septum. Br Heart J. 1993. 69:347–351.

16. Cheatham JP, Coe JY, Kugler JD, Fletcher SE, Tower AJ. Successful transcatheter perforation of the atretic pulmonary valve membrane in a newborn using the new Coe radiofrequency end hole catheter. Cathet Cardiovasc Diagn. 1998. 45:162–166.

17. Coe JY, Chen RP, Dyck J, Byrne P. Transaortic balloon valvoplasty of the pulmonary valve. Am J Cardiol. 1996. 78:124–126.

18. Park IS, Nakanishi T, Nakazawa M, Takanashi Y, Imai Y, Momma K. Radiofrequency pulmonary valvotomy using a new 2-French catheter. Cathet Cardiovasc Diagn. 1998. 45:37–42.

19. Latson L, Cheatham J, Froemming S, Kugler J. Transductal guidewire "rail" for balloon valvuloplasty in neonates with isolated critical pulmonary valve stenosis or atresia. Am J Cardiol. 1994. 73:713–714.

20. Atz AM, Wessel DL. Inhaled nitric oxide in the neonate with cardiac disease. Semin Perinatol. 1997. 21:441–455.

21. Adatia I, Atz AM, Jonas RA, Wessel DL. Diagnostic use of inhaled nitric oxide after neonatal cardiac operations. J Thorac Cardiovasc Surg. 1996. 112:1403–1405.

22. Beghetti M, Morris K, Cox P, Bohn D, Adatia I. Inhaled nitric oxide differentiates pulmonary vasospasm from vascular obstruction after surgery for congenital heart disease. Intensive Care Med. 1999. 25:1126–1130.

23. Journois D, Pouard P, Mauriat P, Malhère T, Vouhé P, Safran D. Inhaled nitric oxide as a therapy for pulmonary hypertension after operations for congenital heart defects. J Thorac Cardiovasc Surg. 1994. 107:1129–1135.

24. Miller OI, Celermajer DS, Deanfield JE, Macrae DJ. Very-low-dose inhaled nitric oxide: a selective pulmonary vasodilator after operations for congenital heart disease. J Thorac Cardiovasc Surg. 1994. 108:487–494.

25. Curran RD, Mavroudis C, Backer CL, Sautel M, Zales VR, Wessel DL. Inhaled nitric oxide for children with congenital heart disease and pulmonary hypertension. Ann Thorac Surg. 1995. 60:1765–1771.

26. Luciani GB, Chang AC, Starnes VA. Surgical repair of transposition of the great arteries in neonates with persistent pulmonary hypertension. Ann Thorac Surg. 1996. 61:800–805.